Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y010930 | — |
HCP reported a lot of PROQUAD was administered on 23MAY2025 after the product experienced a temperature excursion on 19MAY2025. No symptoms reported. HCP consented to correspondence. See related AE case 02817288. No additional AEs/No PQC reported; No symptoms reported; This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's medical history, historical drugs, known drug allergies, concurrent conditions, and concomitant therapies were not reported. On 19-May-2025, doses of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) solution for injection, underwent a temperature excursion of 10.5F for an hour (no previous excursions had occurred), and was later administered to the patient on 23-May-2025, lot #Y010930, expiration date 14-Dec-2025, reconstituted with sterile diluent (MERCK STERILE DILUENT) solution for injection (lot #1950636, expiration date: 22-Jan-2026), at a dose of 0.5 mL as prophylaxis by a health professional (route of administration and anatomical location were not reported) (Improper storage of product in use). However, no symptoms were reported.
Diluent Mrk